这种药物的设计很特别，它是利用一种称为OROS的制造方法，激光打孔技术，在胶囊药物（该胶囊是由人类在体外排泄的粪便不被吸收），创下了孔在前方，使得药物可以缓慢释放。胶囊被分为三个部分，最下面的部分是一个推进机构，中间是高浓度的药物，该药物的浓度是低的前面，然后包裹药物的外层上。因此，考虑使用Concerta专思达后，外层是首次发布的药品，行动可以开始下一阶段的推进机制，将吸收的水分在胃里15分钟内慢慢膨胀胶囊药物释放，启动前的低剂量剂量，中，随剂量的前部慢慢混合，药物浓度在剂量的释放开始时，最终的高剂量胶囊后推半路上，以维持所需的药物PM剂量。这种药剂旨在让孩子每天持续治疗。 < / P >
专司达在早晨服用一次，作用可维持12小时。儿童用药的数量中午取出，使他们的隐私和安全性提高，但也容易让孩子在晚上完成家庭作业，并改善亲子生活。在美国小儿科学会的建议，专司达是治疗的第一线，是美国目前使用药物的人的最大数目
Concerta - Concerta is a central nervous system stimulant used most commonly in the treatment of attention-deficit disorders in children and for narcolepsy. Its mechanisms appear to be similar to those of dextroamphetamine.
Indication: For use as an integral part of a total treatment program which typically includes other remedial measures (psychological, educational, social) for a stabilizing effect in children with a behavioral syndrome characterized by the following group of developmentally inappropriate symptoms: moderate-to-severe distractibility, short attention span, hyperactivity, emotional lability, and impulsivity.
Concerta is a central nervous system stimulant. It affects chemicals in the brain and nerves that contribute to hyperactivity and impulse control.
Concerta is used to treat attention deficit disorder (ADD), attention deficit hyperactivity disorder (ADHD), and narcolepsy.
Concerta may also be used for other purposes not listed in this medication guide.
Treatment of attention-deficit hyperactivity disorder (ADHD). The efficacy of Concerta in the treatment of ADHD was established in controlled trials of children and adolescents aged 6-17 and adults aged 18-65 who met DSM-IV criteria for ADHD. Concerta should be used as a part of a comprehensive treatment program where remedial measures alone prove insufficient. A comprehensive treatment program for the treatment of ADHD may include other measures (psychological, educational, social) for patients with this disorder. Diagnosis must be made according to DSM-IV criteria or the guidelines in ICD-10 and should be based on a complete history and evaluation of the patient. Concerta is not indicated in all patients with ADHD and the decision to use the drug must be based on a very thorough assessment of the severity of the patient's symptoms. Stimulants are not intended for use in the patient who exhibits symptoms secondary to environmental factors and/or other primary psychiatric disorders including psychosis. Appropriate educational placement is essential and psychosocial intervention is often helpful. Specific etiology of the syndrome is unknown and there is no single diagnostic test. Adequate diagnosis requires the use of medical and special psychological, educational, and social resources. Learning may or may not be impaired.
Concerta is used to treat attention deficit hyperactive disorder (ADHD). People with ADHD may have problems concentrating on a given task and may have short attention spans. They may also be impulsive, restless and hyperactive. Concerta is meant to be taken as part of a complete ADHD care programme which includes psychological, educational and social measures. Concerta is also used to treat excessive daytime sleepiness (narcolepsy).
Attention Deficit Hyperactivity Disorder (ADHD) Concerta ®
Treatment of attention deficit hyperactivity disorder (ADHD). The efficacy of Concerta in the treatment of ADHD was established in 3 controlled trials of children 6-12 years who met DSM-IV criteria for ADHD. Concerta should be used as a part of a comprehensive treatment program where remedial measures alone prove insufficient. A comprehensive treatment program for the treatment of ADHD may include other measures (psychological, educational, social) for patients with this disorder. Diagnosis must be made according to DSM-IV criteria or the guidelines in ICD-10 and should be based on a complete history and evaluation of the patient. Concerta treatment is not indicated in all patients with ADHD and the decision to use the drug must be based on a very thorough assessment of the severity of the patient's symptoms. Stimulants are not intended for use in the patient who exhibits symptoms secondary to environmental factors and/or other primary psychiatric disorders, including psychosis. Appropriate educational placement is essential, and psychosocial intervention is often helpful. Specific etiology of this syndrome is unknown, and there is no single diagnostic test. Adequate diagnosis requires the use of medical and special psychological, educational and social resources. Learning may or may not be impaired.
Treatment of Attention Deficit Hyperactivity Disorder (ADHD). The efficacy of Concerta in the treatment of ADHD was established in 3 controlled trials of children aged 6-12 years who met DSM-IV criteria for ADHD.
Treatment of attention deficit hyperactivity disorder (ADHD). The efficacy of Concerta in the treatment of ADHD was established in controlled trials of children and adolescents 6-17 years and adults 18-65 years who met DSM-IV criteria for ADHD. Concerta should be used as a part of a comprehensive treatment program where remedial measures alone prove insufficient. A comprehensive treatment program for the treatment of ADHD may include other measures (psychological, educational, social) for patients with this disorder. Diagnosis must be made according to DSM-IV criteria or the guidelines in ICD-10 and should be based on a complete history and evaluation of the patient. Concerta treatment is not indicated in all patients with ADHD and the decision to use the drug must be based on a very thorough assessment of the severity of the patient's symptoms. Stimulants are not intended for use in the patient who exhibit symptoms secondary to environmental factors and/or other primary psychiatric disorders, including psychosis. Appropriate educational placement is essential and psychosocial intervention is often helpful. Specific etiology of this syndrome is unknown and there is no single diagnostic test. Adequate diagnosis requires the use of medical and special psychological, educational and social resources. Learning may or may not be impaired.
Concerta is a central nervous system stimulant. It affects chemicals in the brain and nerves that contribute to hyperactivity and impulse control. Exactly how it works is not known. Methylphenidate is used to treat attention deficit disorder (ADD), attention deficit hyperactivity disorder (ADHD). It is also used to treat uncontrollable periods of daytime sleep (narcolepsy).
国际免费电话：